- age less than 18 years old and over 59 years old - pregnancy or breastfeeding - hypersensitivity, allergy, intolerance to iodine, iodine-containing medicines - hypersensitivity to remdesivir or its components - impaired consciousness, causing the impossibility of oral administration - conditions or circumstances that, in the opinion of the investigator, may affect the patient's safety or the quality of the results obtained - participation in another clinical trial, including in the period up to 2 months before this study - signs of multiple organ failure - alanine aminotransferase (alt), aspartate aminotransferase (ast) is 5 or more times higher than normal - thrombocytopenia below 100 * 10^9/ l - decrease in glomerular filtration rate (gfr) less than 30 ml / min by 1.73 m2 - chronic heart failure with reduced ejection fraction - liver failure - coagulopathy - mechanical ventilation for 48 hours or more - extracorporeal membrane oxygenation (ecmo) - disseminated intravascular coagulation

- age less than 18 years old and over 59 years old - pregnancy or breastfeeding - hypersensitivity, allergy, intolerance to iodine, iodine-containing medicines - hypersensitivity to remdesivir or its components - impaired consciousness, causing the impossibility of oral administration - conditions or circumstances that, in the opinion of the investigator, may affect the patient's safety or the quality of the results obtained - participation in another clinical trial, including in the period up to 2 months before this study - signs of multiple organ failure - alanine aminotransferase (alt), aspartate aminotransferase (ast) is 5 or more times higher than normal - thrombocytopenia below 100 * 10^9/ l - decrease in glomerular filtration rate (gfr) less than 30 ml / min by 1.73 m2 - chronic heart failure with reduced ejection fraction - liver failure - coagulopathy - mechanical ventilation for 48 hours or more - extracorporeal membrane oxygenation (ecmo) - disseminated intravascular coagulation